B I09
B I09 is an IRE-1 RNase inhibitor, with an IC50 of 1230 nM.
Product Specifications
CAS Number
1607803-67-7
UNSPSC
12352005
Target
IRE1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/B_I09.html
Purity
99.35
Solubility
DMSO : 11.11 mg/mL (ultrasonic)
Smiles
OC1=CC=C(C2=C(CNCC2)C3=O)C(O3)=C1C4OCCCO4
Molecular Formula
C16H17NO5
Molecular Weight
303.31
References & Citations
[1]Ranatunga S, et al. Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. J Med Chem. 2014 May 22;57 (10) :4289-301.|[2]Tang CH, et al. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J Clin Invest. 2014 Jun;124 (6) :2585-98.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY424888 100 µg
Glycerol kinase (GK) (NM_000167) Human Over-expression Lysate
Sign In for Pricing
View Details 
